← Back to Search

Procedure

Phonak Lyric self-replacement procedure for Neonatal Hearing Loss

N/A
Waitlist Available
Research Sponsored by Sonova AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 months
Awards & highlights
No Placebo-Only Group

Summary

This trial investigates if people who use the Phonak Lyric hearing aid can safely and effectively replace it themselves, instead of needing a healthcare professional.

Eligible Conditions
  • Neonatal Hearing Loss
  • Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in aided audiometric threshold testing between standard and experimental replacement procedures
Change in aided speech-in-noise testing between standard and experimental replacement procedures
Secondary study objectives
Change in incidence of medical referrals secondary to device replacement procedure-related ear health outcome between standard and experimental replacement procedures
Other study objectives
Change in incidence of acoustic feedback across device replacement procedures
Change in incidence of provider/clinical support needed across device replacement procedures
Change in measured device position at replacement between standard and experimental replacement procedures

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lyric self-replacementExperimental Treatment1 Intervention
This cohort of experienced Lyric patients are required to meet the candidacy criteria to be eligible for the self-replacement procedure. They will also be required to demonstrate proficiency with the self-replacement procedure before proceeding with independent self-replacement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phonak Lyric self-replacement procedure
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Sonova AGLead Sponsor
80 Previous Clinical Trials
1,871 Total Patients Enrolled
AccuData SolutionsUNKNOWN
Grace Gardner, AuDStudy DirectorSonova USA Inc
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top